Biomarkers of aging, life span and spontaneous carcinogenesis in the wild type and HER-2 transgenic FVB/N female mice

[1]  Chen-Yu Liao,et al.  Mouse models and aging: longevity and progeria. , 2014, Current topics in developmental biology.

[2]  M. Provinciali,et al.  Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice. , 2013, Carcinogenesis.

[3]  V. Anisimov,et al.  Methods of testing pharmacological drugs effects on aging and life span in mice. , 2013, Methods in molecular biology.

[4]  M. Provinciali,et al.  Effect of annatto-tocotrienols supplementation on the Development of Mammary Tumors in HER-2/neu Transgenic Mice , 2012 .

[5]  L. Strizzi,et al.  Effects of Age and Parity on Mammary Gland Lesions and Progenitor Cells in the FVB/N-RC Mice , 2012, PloS one.

[6]  Carolina Gutierrez,et al.  HER2: biology, detection, and clinical implications. , 2011, Archives of pathology & laboratory medicine.

[7]  M. Antoch,et al.  Rapamycin extends maximal lifespan in cancer-prone mice. , 2010, The American journal of pathology.

[8]  V. Anisimov,et al.  Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo , 2010, Cell cycle.

[9]  R. Cardiff,et al.  Mammary Tumor Phenotypes in Wild-Type Aging Female FVB/N Mice with Pituitary Prolactinomas , 2009, Veterinary pathology.

[10]  R. Jain,et al.  Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB/N mice. , 2008, Comparative medicine.

[11]  V. Anisimov,et al.  [Apoptosis regulation in hypothalamic neurosecretory cells of HER2/neu transgenic mice in ontogenesis]. , 2007, Advances in gerontology = Uspekhi gerontologii.

[12]  N. Nadon.  Exploiting the rodent model for studies on the pharmacology of lifespan extension , 2006, Aging cell.

[13]  C. Franceschi,et al.  Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice , 2005, Experimental Gerontology.

[14]  Jose J. Galvez,et al.  Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling. , 2003, Comparative medicine.

[15]  A. Peiris,et al.  Insulin: a novel factor in carcinogenesis. , 2002, The American journal of the medical sciences.

[16]  I. Popovich,et al.  The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. , 2001, Neuro endocrinology letters.

[17]  V. Anisimov,et al.  Mutant and genetically modified mice as models for studying the relationship between aging and carcinogenesis , 2001, Mechanisms of Ageing and Development.

[18]  D. Ingram,et al.  Developing mouse models of aging: a consideration of strain differences in age-related behavioral and neural parameters☆ , 1999, Neurobiology of Aging.

[19]  W. Muller,et al.  Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer. , 1998, Biochemical Society symposium.

[20]  R. Maronpot,et al.  Spontaneous Lesions in Aging FVB/N Mice , 1996, Toxicologic pathology.

[21]  S. Yuspa,et al.  FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. , 1993, Carcinogenesis.

[22]  T. Roderick,et al.  FVB/N: an inbred mouse strain preferable for transgenic analyses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Leder,et al.  Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.

[24]  J. Moore,et al.  Pathology of Tumours in Laboratory Animals , 1981, British Journal of Cancer.